Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tryptamine Therapeutics Limited (AU:TYP)
ASX:TYP
Tryptamine Therapeutics (TYP) Ownership - Who Owns Tryptamine Therapeutics?
7 Followers
Tryptamine Therapeutics (TYP) Ownership Overview
6.09% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
93.91% Public Companies and
Individual Investors
The ownership structure of Tryptamine Therapeutics (AU:TYP) stock is a mix of institutional, retail and individual investors. Approximately 0.00% of the company’s stock is owned by Institutional Investors, 6.09% is owned by Insiders and 93.91% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 17, 2024 | Jason Alan Carroll Non Executive,director | xxxxxxxxxxxxx | AU$11974 |
| Jun 07, 2024 | Jason Alan Carroll Non Executive,director | xxxxxxxxxxxxx | AU$36051 |
| Jun 06, 2024 | Jason Alan Carroll Non Executive,director | xxxxxxxxxxxxx | AU$20960 |
| Jun 04, 2024 | Jason Alan Carroll Non Executive,director | xxxxxxxxxxxxx | AU$25000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 36,750,000 | Insider | 3.23% | 735,000 | |
| 28,258,627 | Insider | 2.48% | 565,173 | |
| 2,000,000 | Insider | 0.18% | 40,000 | |
| 1,092,200 | Insider | 0.10% | 21,844 | |
| 760,000 | Insider | 0.07% | 15,200 | |
| 508,000 | Insider | 0.04% | 10,160 | |
| 30,000 | Insider | <0.01% | 600 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Tryptamine Therapeutics Limited (AU:TYP)?
According to the latest TipRanks data, approximately 0.00% of the company's stock is held by institutional investors, 6.09% is held by insiders, and 93.91% is held by retail investors.
What percentage of Tryptamine Therapeutics Limited (AU:TYP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.00% of Tryptamine Therapeutics Limited (AU:TYP) stock is held by institutional investors.
What percentage of Tryptamine Therapeutics Limited (AU:TYP) stock is held by retail investors?
According to the latest TipRanks data, approximately 93.91% of Tryptamine Therapeutics Limited (AU:TYP) stock is held by retail investors.
Who owns the most shares of Tryptamine Therapeutics Limited (AU:TYP)?
Jason Alan Carroll owns the most shares of Tryptamine Therapeutics Limited (AU:TYP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.